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In this work, sodium alginate microcapsules containing cedarwood essential oil (CWO) 
for uses in anti-acne tonic were prepared by ionic gelification of alginate with calcium chloride 
(CaCl2) and subsequent addition of glutaraldehyde to improve the crosslinking degree. Alginate 
microcapsules with cedarwood essential oil were obtained in an encapsulator with a 600 µm 
nozzle using different alginate concentrations (1, 3 and 4% w/v) , and different compositions of 
the coagulation solution with CaCl2 concentrations of 0.1, 0.25 and 0.5 M, and addition of 
glutaraldehyde at two concentrations: 12.5% and 50 % (0.1 g L-1 and 10 g L-1 respectively). The 
effect of alginate concentration was followed by viscosimetry and the influence of the CaCl2 
concentration and presence of glutaraldehyde on the microcapsules’ shape as well as the total 
content on encapsulated cedarwood essential oil were evaluated by means of stereoscopic 
magnifying glass, scanning electron microscopy (SEM) and UV-vis spectrophotometry. Results 
show that proper shape formation is obtained for an alginate concentration of 3% w/v. With regard 
to the total encapsulated cedarwood oil, as the CaCl2 concentration in the gelifying-coagulating 
solution increases the efficiency of the encapsulated oil. Best results in terms of micro-bead shape 
and total amount of encapsulated oil were obtained for a CaCl2 concentration of 0.5 M without 
glutaraldehyde with a maximum encapsulation of 177.2 mg per gram of microcapsule. 
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Introduction 
 Cedarwood oil (CWO) is an essential oil that is generally obtained from Juniperus 
species. For many centuries, the leaves, berries and essential oils from Juniperus have been used 
as cosmetics and for medical purposes [1]. The main chemical compounds contained in 
cedarwood essential oil are cedrol (13-15%), widdrol (9-12%), 8,14-cedranoxide (7-8%), 14-
hydroxy-E-caryophyllene (5-9%), cis-thujopsene (10-11%) and a-cedrene (6-8%) [2]. Some 
studies have revealed the antifungal, anti-termite and anti-inflammatory properties of cedarwood 
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oil [3,1]. Cedarwood essential oil is widely used in fragrances as well as flavored soaps, aerosols 
and sprays, disinfectant agents, cleaning of microscope parts and immersion lens [2].  
 Microencapsulation is a packing technique in which a material or a mixture of materials 
in the liquid form, small solid particles or even in the gas state are covered or trapped inside 
another material, typically a polymer, with the main aim of immobilizing, protecting or 
maintaining the bioactivity of the encapsulated chemical. Degradation of the polymer entrapment 
can lead to a controlled release rate of the encapsulated compound [4-6]. In the last years a 
remarkable increase in the microencapsulation technology has been detected, with a wide variety 
of applications in different sectors. Among others, the use of microcapsules or micro-beads is 
generalized in industries such as pharmaceutics, chemical, food, perfumery, textile, agriculture, 
etc.  [4,7-11]. 
 Recently, microcapsules from alginate-based polymers have acquired great relevance as 
they can be used as controlled delivery systems due to its biodegradability. In addition, alginate 
is nontoxic, hemocompatible and offers high stability to the encapsulated compound. For these 
reasons, research has focused on the use of alginate-based microcapsules as drug carrier and 
delivery systems for the pharmaceutical industry [12] and in bioengineering and biomedicine 
applications [13-18]. Alginate is a linear non branched polysaccharide obtained from brown 
marine algae and it mainly consists on linear polymeric chains from α-l-guluronic acid and β-D-
mannuronic acid residues joined by 1,4-glycosidic linkages [19,20]. One of the most relevant 
features of alginate polymers is their ability to form gel structures by reaction with divalent cations 
such as Ca2+ [21]. Typical alginate microcapsules can be obtained by extrusion of the alginate-
containing solution in the form of drops over the crosslinking solution with divalent cations such 
as Ca2+, Sr2+, Ba2+ [22].  
 The main aim of this work is to obtain alginate-based microcapsules containing 
cedarwood essential oil (CWO) as potential anti-acne material for uses in cosmetic tonics. 
Optimization of the microencapsulation process is carried out by varying concentrations and 
process parameters. The influence of sodium alginate concentration (polymer-based solution), 
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CaCl2 concentration (gelling solution) and glutaraldehyde (crosslinking agent) on the 




 Alginic acid sodium salt from brown algae (low glucuronic content with low viscosity, 
4–12 cPs, 1% in H2O at 25 °C) and calcium chloride (CaCl2) were supplied by Sigma Aldrich 
(Sigma Aldrich, Madrid, Spain). Two glutaraldehyde solutions at 12.5% and 50%, supplied by 
Corquimia Industrial (Corquimia Industrial S.L., Barcelona, Spain) were used as crosslinking 
agent. Glutaraldehyde was selected to its wide use in the textile industry as crosslinker. These two 
particular concentrations are typical of crosslinking processes of alginate [23] and were also 
recommended by the supplier. Cedarwood essential oil (CWO) was supplied by Esencias 
Martínez Lozano (Esencias Martínez Lozano, S.A., Murcia, Spain). In addition, colorant Conasol 
3-C supplied by Proquimac PFC (PROQUIMAC PFC SA, Barcelona, Spain) was used to stain 
cedarwood thus avoiding a better observation of the encapsulation oil. 
 
Cedarwood oil activity against acne 
 The benefits of cedarwood oil for acne treatment were tested by measuring its bacterial 
activity against Propionibacterium acnes. The test was conducted with Tryptone soya broth 
(TSB) and the culture medium was plate count agar (PCA). The contact time with the 
microorganism was 24 h and the incubation time of plates was 24 h at a temperature of 35 ºC. 
 
Preparation of CWO encapsulated by alginate microcapsules 
 Alginate solution was prepared with sodium alginate in distilled water at different 
concentrations: 1, 3 and 4% w/v. The solution mixture was homogenized using an Ultra-turrax 
T18 homogenizer (IKA, Staufen, Germany) at 5000 rpm for 5 min. Alginate droplets with 
cedarwood oil were generated with an encapsulator B-390 pro from Büchi (Essen, Germany) 
equipped with a concentric nozzle system with an inner nozzle diameter of 300 µm and an outer 
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nozzle diameter of 600 µm. The droplets were generated at a fixed frequency of 400 Hz and an 
electrode tension of 250 V and were continuously dropped onto a CaCl2 solution at different 
concentrations (0.5, 0.25 and 0.1 M) and two different glutaraldehyde compositions (0.1 g L-1 and 
10 g L-1). Gelation of alginate microcapsules was maintained for 30 min at a rotating speed of 100 





 In a first stage, the alginate concentration varied from 1% to 4% w/v to find the optimum 
concentration in terms of solution viscosity and the spherical shape of the obtained microcapsules, 
measured by optical microscopy. After this initial stage, the alginate concentration was 
maintained constant and then, the gelling solution composition was optimized by varying the 
CaCl2 concentration (0.1M, 0.25M and 0.5M) and glutaraldehyde (0.1 g L-1 and 10 g L-1).  
 
Viscosity of the alginate polymer solution 
The easiness of extrusion of the alginate polymer solution through the encapsulator nozzle 
is directly related to the solution viscosity. For this reason, rotational viscosity of polymer 
solutions with different alginate concentrations was measured with a Brookfield viscometer DV-
I Prime (Brookfield Engineering Laboratories, Inc, Massachusetts, USA) equipped with a 
RV/HA/HB-2 spindle at a rotating speed of 100 rpm. 
 
Morphology and size of the CWO encapsulated alginate microcapsules 
 The shape of the wet microcapsules was examined by a digital camera Canon coupled to 
a stereoscopic magnifying glass Olympus SZX7 (Olympus Corp., Japan). Optical microscopy 
allowed observation of the encapsulated oil, previously stained with a specific colorant and a 
warped shape of microcapsules. The average size and spherical shape could not be observed in 
the wet form. For this reason, microcapsules were previously dried (1 h at 50 ºC) and, 
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subsequently, observed by scanning electron microscopy (SEM) in a Phenom microscope from 
FEI Company (Eindhoven, Netherlands). Prior to observation, dry microcapsules were subjected 
to a coating process with an aurum-palladium alloy for 135 s in a sputter coated EMITECH mod. 
SC7620 from Quorum Technologies Ltd. (East Sussex, UK) 
 
Determination of the encapsulated cedarwood essential oil into alginate microcapsules  
 The total content of encapsulated cedarwood essential oil (CWO) was determined by 
weighing a fixed weight of microcapsules (500 mg) and diluting them into 5 g ethanol. After this, 
the ethanol solution was placed in an ultrasonic bath sonicator for 10 min to allow microcapsule 
breakage and subsequently subjected to centrifugation in a SCANSPEED mod. 1248 from 
Labogene ApS (Lynge, Denmark) at a rotating speed of 3000 rpm for 5 min. The supernatant was 
collected and the total amount of encapsulated cedarwood essential oil was determined by UV-
vis spectrophotometry at a wavelength of 326 nm using a Hach Lange DR-3900 
spectrophotometer (Düsseldorf, Germany). 
The encapsulation efficiency of cedarwood essential oil into alginate-based 
microcapsules was calculated by considering the total amount of cedarwood used in the 
encapsulation (WCWO_T) and the remaining cedarwood essential oil contained in the supernatant 
after centrifugation (WCWO_S) (this stands for the total encapsulated cedarwood essential oil). The 








Cytotoxicity test MMT 
As these microcapsules are intended to be used in cosmetics, it is important to assess their 
potential cytotoxicity as they are going to be in contact with the skin. For this reason, cytotoxicity 
of alginate microcapsules was tested in vitro with L929 cells (mouse fibroblasts) by the MMT 
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photocolorimetric assay based on the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) as indicated in the ISO 10993-5 standard. This standard is designed 
to determine the response of mammalian cells in vitro. A cell culture medium without alginate 
microcapsules with cedarwood oil was used as the negative control for the viability assay. L929 
cells were incubated in a DMEM medium (Dulbecco’s modification of Eagle’s medium) as 
recommended by ISO 10993-5 standard as it is a specific medium for mammalian cells culture, 
with additional fetal bovine serum and L-glutamine (Glutamax). All the tests were carried out in 
triplicate. 
Cells were cultured at a density of approx. 2·104 cells per well in plates containing 96 
wells for a period of 24 h at a constant temperature of 37 ºC and 5% CO2 in wet atmosphere 
(higher than 90%) in triplicate. After this, different concentrations of alginate microcapsule with 
cedarwood oil were added (10 and 500 µg mL-1) and the plates were incubated for an additional 
period of 24 h with the same conditions. These concentrations were selected to cover a wide range 
of bioactivity at very low and very high concentrations. After incubation, the supernatant was 
removed and MTT was added; then incubation was kept for 2 h at 37 ºC. The precipitated 
formazan was dissolved in dimethyl sulfoxide (DMSO) and the absorbance and optical density 
(OD) was measured at a wavelength of 550 nm in a microplate reader (Multiskan Ascent). Cell 
survival was determined by comparison of the absorbance values obtained for treated and non-
treated cells. The total amount of live cells was then correlated to the generated formazan with 
the following equation: 
 





If the cell viability of cultures with alginate microcapsules is lower than values of 70% of 
the negative control culture, then the material has potential cytotoxicity and if this value is lower 





Results and Discussion 
The anti-acne of cedarwood essential oil has been checked by its activity against 
Propionibacterium acnes. The antimicrobial effect is evident as the microorganism reduction that 
cedarwood essential oil gives is 99.99%, thus showing its potential in cosmetics. 
Fig. 1 shows an optical image of the wet microcapsules. The encapsulated cedarwood 
essential oil appears blue-stained to observe the efficiency of the encapsulation process. We can 
clearly see that low concentrations of 1% w/v provide very low viscosity (3160 cP) and the 
solution is too much fluent so that microcapsules cannot be formed in an appropriate way. On the 
other hand, an alginate concentration of 4% w/v leads to a thick solution with a viscosity of 14760 
cP which leads to a microcapsule aggregation. Best results are obtained for an alginate 
concentration of 3% w/v with intermediate viscosity values of 9840 cP.  
 
Fig. 1  
 
Considering these results, the alginate concentration has been maintained constant at a 
fixed value of 3% w/v and the effect of the CaCl2 and glutaraldehyde concentration ion the gelling 
solution has been tested. Fig. 2 shows optical images obtained with a stereoscopic magnifying 
glass for microcapsules obtained with constant alginate concentration (3% w/v) in the polymer 
solution and different CaCl2 concentrations in the gelling solution (0.1M, 0.25M and 0.5M) as 
well as different crosslinking agent (glutaraldehyde), 0.1 g L-1 and 10 g L-1). As we can see, all 
microcapsules (in the wet form) show an oval shape in which, both the gelled alginate shell and 
the encapsulated cedarwood essential oil (CWO) can be detected due to the previous blue-staining 
of the CWO. The effect of CaCl2 as ionic gelation agent has been widely described in the literature 
[13,24,25]. In general the shapes are quite homogeneous and slight changes can be detected as a 
consequence of the CaCl2 and glutaraldehyde concentrations. Higher CaCl2 concentrations lead 
to more circular capsules. With regard to glutaraldehyde, it has no a clear effect on overall shape 






Table 2 shows a summary of the total encapsulated cedarwood essential oil related to 1 g 
microcapsule in terms of the CaCl2 and glutaraldehyde concentrations in the gelling solution. As 
we can see the maximum encapsulation is obtained with solutions without glutaraldehyde and, 
additionally, the encapsulated amount increases with increasing CaCl2 concentration with values 
of 173.7 and 177.2 mg CWO per gram capsule for 0.25M and 0.5M respectively. Presence of 
glutaraldehyde leads to more crosslinked structures but the amount of encapsulated cedarwood 
essential oil is lower. So that, for a CaCl2 concentration of 0.1M, maximum encapsulation 
efficiency is obtained with gelling solutions containing 10 g L-1 glutaraldehyde (12.5% solution) 
with an encapsulated mass of 175.5 mg, slightly higher that microcapsules obtained with same 
CaCl2 concentration and low glutaraldehyde concentration (0.1 g L-1 glutaraldehyde at 12.5%) 
leading to an encapsulated mass of 168.4 mg. The use of concentrated solution of glutaraldehyde 
(50%) leads to an overall decrease in the encapsulated CWO. As it can be observed in Table 2, 
maximum efficiency of the encapsulation process is achieved for a gelling solution with 0.5M 




 The encapsulation efficiency (EE%) has been determined for the optimized conditions 
(polymer solution with 3% w/v alginate, gelling solution with 0.5M CaCl2 and no glutaraldehyde) 
by considering the amount of cedarwood oil used in the process and the total amount that has 
been trapped or encapsulated inside alginate shells (average values are summarized in Table 3). 
An average encapsulation efficiency of 65% is obtained with these conditions and this represents 






 Fig. 3 shows a SEM image corresponding to dry microcapsules obtained with the 
optimum conditions as previously indicated. Wet microcapsules were dried at 50 ºC for 1 h to 
study the shape and size of the synthesized microcapsules. As we can see, when microcapsules 
are dry, the shape is clearly spherical with a smooth surface topography. The average diameter is, 
obviously close to 600 µm as the nozzle diameter is 600 µm. 
 
Fig. 3  
 
 The effect of different concentrations of alginate beads with encapsulated cedarwood oil 
on cell viability (L929 cells after 24 h incubation) was studied by the MTT assay. Fig. 4 shows 
cell viability of L929 cells for different concentrations. As one can see, addition of alginate 
capsules with CWO leads to a slight increase in cell viability with values of about 107% and 
111% for alginate concentrations of 10 µg mL-1 and 500 µg mL-1 respectively. Obviously, these 
values indicate that alginate beads containing cedarwood oil are not cytotoxic (cell viability 
remarkably higher than 70%) thus showing that these microcapsules can be used in the cosmetic 
industry for applications in direct contact with skin. 
 
Fig. 4  
 
 Fig. 5 shows images of the cell proliferation after an incubation period of 24 h for cultures 
with different microcapsule concentrations in comparison to the control culture. As it can be 
observed a slight increase in cell density can be observed for both concentrations so that giving a 







 This work has focused on the development of bioactive microcapsules containing 
cedarwood essential oil (CWO) into an alginate shell obtained by gelation with CaCl2. The study 
of the viscosity of the polymer solution in terms of sodium alginate concentration revealed a clear 
effect of the solution viscosity on the ability to form homogeneous-individual microcapsules. 
Optimum results were obtained with an alginate concentration of 3% w/v. Alginate concentration 
of 1% w/v gives very low viscosity and microcapsules are not formed in an appropriate way while 
alginate concentrations of 4% w/v give thick pastes that lead to microcapsule aggregates. Other 
parameters influencing the encapsulation efficiency and the morphology of the synthesized 
microcapsules were the concentrations of the gelling agent, CaCl2 and the potential use and 
concentration of a crosslinker such as glutaraldehyde. For a fixed alginate concentration of 3% 
w/v, maximum encapsulation efficiency of about 65% (estimated as the ratio between the 
encapsulated oil and the total oil used) is obtained with a CaCl2 concentration of 0.5M without 
crosslinker. Glutaraldehyde can contribute to increase hardness and durability of the alginate shell 
but it has a negative effect on the overall yield of encapsulation. The high encapsulation efficiency 
(approx. 177 mg cedarwood oil per gram microcapsule) in conjunction with its easy 
decomposition, its absence of cytotoxicity and the intrinsic antibacterial properties of cedarwood 
essential oil, make these microcapsules very attractive and useful for the cosmetics industry with 
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Table 1 Microcapsules’ formulations and main process conditions of the encapsulation of 
cedarwood essential oil into alginate microcapsules.  
Microcapsules’ formulations 
Component Concentration 
Encapsulation polymer: alginate 1, 3, 4 % (w/v) 
Coagulating agent: CaCl2 0.1, 0.25, 0.5 M 
Crosslinker: glutaraldehyde 0.1, 10 g L-1 
Microencapsulation parameters 
Variable Value 
frequency 400 Hz 
electrode tension 200 V 
nozzle size 600 µm 





Table 2 Values of amount of encapsulated cedarwood essential oil (mg CWO per gram 
microcapsule) in terms of the concentration of CaCl2 and glutaraldehyde in the gelling solution. 
CaCl2 concentration 
       Without 
crosslinking 
agent 





0.1 g L-1 10 g L-1 0.1 g L-1 10 g L-1 
0.10M 160.0 168.4 175.5 141.2 141.7 
0.25M 173.7 144.3 143.5 110.4 128.4 






Table 3 Average values of the weights of total cedarwood oil (WCWO_T) used in the process and 
encapsulated oil (WCWO_S) trapped inside the alginate shells.  
Total weight of cedarwood oil used (WCWO_T), g 4.37 
Weight of encapsulated cedarwood oil (WCWO_S), g 2.84 





Fig. 1 Optical images of the microcapsules obtained with different alginate concentrations in the 
polymer solution a) 1% w/v, b) 3% w/v and c) 4% w/v 
Fig. 2 Optical images of the microcapsules obtained with a constant alginate concentration of 3% 
w/v and different CaCl2 and glutaraldehyde concentrations in the gelling solution 
Fig. 3 SEM images of cedarwood alginate microcapsules obtained with optimized conditions 
Fig. 4 Cell viability (L929 cells after 24 h incubating at 37 ºC) of cultures with different 
concentrations of cedarwood oil encapsulated alginate beads 
Fig. 5 Images of the L929 cells proliferation after 24 h for cultures with different concentrations 
of cedarwood oil encapsulated alginate beads 
